OBJECTIVE: To assess children with retinopathy-positive cerebral malaria (CM) for neurocognitive sequelae. METHODS: Participants were selected from an ongoing exposure-control study. Eighty-three Malawian children averaging 4.4 years of age and diagnosed with retinopathy-positive CM were compared to 95 controls. Each child was classified as delayed or not using age-based norms for the Malawi Developmental Assessment Tool (MDAT) for developmental delay on the total scale and for the domains of gross motor, fine motor, language and social skills. Groups were also compared on the Achenbach Child Behaviour Checklist (CBCL) (1.5-5 years). RESULTS: Children with retinopathy-positive CM were delayed, relative to the comparison group, on MDAT total development (P = 0.028; odds ratio or OR = 2.13), with the greatest effects on language development (P = 0.003; OR = 4.93). The two groups did not differ significantly on the Achenbach CBCL internalizing and externalizing symptoms total scores. Stepwise regression demonstrated that coma duration, seizures while in hospital, platelet count and lactate level on admission were predictive of assessment outcomes for the children with retinopathy-positive CM. CONCLUSIONS: Children who suffer retinopathy-positive CM at preschool age are at greater risk of developmental delay, particularly with respect to language development. This confirms previous retrospective study findings with school-age children evaluated years after acute illness. The MDAT and the Achenbach CBCL proved sensitive to clinical indicators of severity of malarial illness.
OBJECTIVE: To assess children with retinopathy-positive cerebral malaria (CM) for neurocognitive sequelae. METHODS:Participants were selected from an ongoing exposure-control study. Eighty-three Malawian children averaging 4.4 years of age and diagnosed with retinopathy-positive CM were compared to 95 controls. Each child was classified as delayed or not using age-based norms for the Malawi Developmental Assessment Tool (MDAT) for developmental delay on the total scale and for the domains of gross motor, fine motor, language and social skills. Groups were also compared on the Achenbach Child Behaviour Checklist (CBCL) (1.5-5 years). RESULTS:Children with retinopathy-positive CM were delayed, relative to the comparison group, on MDAT total development (P = 0.028; odds ratio or OR = 2.13), with the greatest effects on language development (P = 0.003; OR = 4.93). The two groups did not differ significantly on the Achenbach CBCL internalizing and externalizing symptoms total scores. Stepwise regression demonstrated that coma duration, seizures while in hospital, platelet count and lactate level on admission were predictive of assessment outcomes for the children with retinopathy-positive CM. CONCLUSIONS:Children who suffer retinopathy-positive CM at preschool age are at greater risk of developmental delay, particularly with respect to language development. This confirms previous retrospective study findings with school-age children evaluated years after acute illness. The MDAT and the Achenbach CBCL proved sensitive to clinical indicators of severity of malarial illness.
Authors: Michael J Boivin; Paul Bangirana; Justus Byarugaba; Robert O Opoka; Richard Idro; Anne M Jurek; Chandy C John Journal: Pediatrics Date: 2007-01-15 Impact factor: 7.124
Authors: Gretchen L Birbeck; Malcolm E Molyneux; Peter W Kaplan; Karl B Seydel; Yamikani F Chimalizeni; Kondwani Kawaza; Terrie E Taylor Journal: Lancet Neurol Date: 2010-11-04 Impact factor: 44.182
Authors: Chandy C John; Paul Bangirana; Justus Byarugaba; Robert O Opoka; Richard Idro; Anne M Jurek; Baolin Wu; Michael J Boivin Journal: Pediatrics Date: 2008-06-09 Impact factor: 7.124
Authors: Richard Idro; Moses Ndiritu; Bernhards Ogutu; Sadik Mithwani; Kathryn Maitland; James Berkley; Jane Crawley; Gregory Fegan; Evasius Bauni; Norbert Peshu; Kevin Marsh; Brian Neville; Charles Newton Journal: JAMA Date: 2007-05-23 Impact factor: 56.272
Authors: Rachel Brim; Sebastian Mboma; Margaret Semrud-Clikeman; Sam Kampondeni; Jed Magen; Terrie Taylor; John Langfitt Journal: Am J Trop Med Hyg Date: 2017-07 Impact factor: 2.345
Authors: Jo M Wilmshurst; Eben Badoe; Robinson D Wammanda; Macpherson Mallewa; Angelina Kakooza-Mwesige; Andre Venter; Charles R Newton Journal: J Child Neurol Date: 2011-10-21 Impact factor: 1.987
Authors: Michael J Boivin; Maclean Vokhiwa; Alla Sikorskii; Jed G Magen; Nicholas A V Beare Journal: Pediatr Infect Dis J Date: 2014-08 Impact factor: 2.129
Authors: Paul Bangirana; Robert O Opoka; Michael J Boivin; Richard Idro; James S Hodges; Regilda A Romero; Elsa Shapiro; Chandy C John Journal: Clin Infect Dis Date: 2014-04-24 Impact factor: 9.079
Authors: John Mbaziira Ssenkusu; James Steven Hodges; Robert Opika Opoka; Richard Idro; Elsa Shapiro; Chandy Chiramukhathu John; Paul Bangirana Journal: Pediatrics Date: 2016-10-05 Impact factor: 7.124
Authors: Margaret Semrud-Clikeman; Regilda Anne A Romero; Elizabeth L Prado; Elsa G Shapiro; Paul Bangirana; Chandy C John Journal: Child Neuropsychol Date: 2016-09-09 Impact factor: 2.500
Authors: Lena Serghides; Chloe R McDonald; Ziyue Lu; Miriam Friedel; Cheryl Cui; Keith T Ho; Howard T J Mount; John G Sled; Kevin C Kain Journal: PLoS Pathog Date: 2014-03-06 Impact factor: 6.823